Immomed SA
Immomed reported total assets of 148,529 € at the end of the 2026 financial year (annual accounts filed with the NBB on 02 Oct 2026).
The score of Immomed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -18 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immomed's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | −7,757 € | ||||
| Equity | 132,374 € | ||||
| Cash | 20,189 € | ||||
| EBITDA | −4,088 € | ||||
| Total assets | 148,529 € |
Filed annual accounts
- Year ended 30 Jun 2026filed on 02 Oct 2026
- Year ended 30 Jun 2025filed on 01 Dec 2025
- Year ended 30 Jun 2024filed on 29 Nov 2024
- Year ended 30 Jun 2023filed on 05 Dec 2023
- Year ended 30 Jun 2022filed on 13 Dec 2022
Immomed's financial analysis
- Solvency89.1%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immomed
Immomed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.808.974
- VAT number
- BE0451808974
- Peppol
- Registered · 0208:0451808974 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 17 Dec 1993
- Registered office
- 8430 Middelkerke
- Latest accounts
- 2026 · filed on 02 Oct 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Immomed (SA) has been based in Middelkerke since 1993, active in: manufacture of basic pharmaceutical products. For 2026, it reports a net loss of 7,757 € and equity of 132,374 €; its revenue is not published. Its solvency stands at 89.1%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immomed
Companies in the same business, of comparable size and area, outside its group.
- Docteur Marie-Caroline MASEREEL Medical specialists activities Awans · balance sheet 148,528 €
- De Letterrups Other real estate activities on a fee or contract basis Heist-op-den-Berg · balance sheet 148,525 €
- Flora infirmière à domicile Nursing and midwifery activities Frasnes-lez-Anvaing · balance sheet 148,536 €
- L'Immobiliere de la Honnelles Rental and operating of own or leased real estate Honnelles · balance sheet 148,518 €
- Louise Bontemps Medecine Generale General medical practice activities Hamois · balance sheet 148,491 €
- Cabinet Médical du Docteur Firescu Radu Medical specialists activities Jurbise · balance sheet 148,489 €
- Residentie de la Fontaine Ghent · balance sheet 148,489 €
- Orthotec Invest Buying and selling of own real estate Seraing · balance sheet 148,575 €
Frequently asked questions about Immomed
What is the revenue of Immomed?
Immomed files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Immomed?
In Belgium, the VAT number is the company number prefixed with BE: BE0451808974 for Immomed, if the company is VAT-registered. Its company number (CBE) is 0451.808.974.
Where is the registered office of Immomed?
According to the CBE register, the registered office of Immomed is in 8430 Middelkerke.
What is the equity of Immomed?
At the close of the 2026 financial year, the equity of Immomed amounts to 132,374 €, a solvency of 89.1% of total assets.
Who manages Immomed?
The register lists 6 active mandates at Immomed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immomed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →